Novartis AG ( NVSEF) - Stock Earnings
NVSEF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 27, 2026 AfterMarket | — / — | — | — / — | — |
NVSEF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 2.4 billion USD | 13.4 billion USD |
| 2026Q1 | 3.1 billion USD | 12.9 billion USD |
| 2026Q2 | 3.2 billion USD | 14.1 billion USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
NVSEF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 14.9 billion USD | 46.7 billion USD |
| 2024 | 11.9 billion USD | 51.7 billion USD |
| 2025 | 14.6 billion USD | 57.1 billion USD |
| 2026 Est. | — | — |
NVSEF
Price: $164.25
Dividend Yield: 2.89%
Forward Dividend Yield: 5.79%
Payout Ratio: 76.50%
Dividend Per Share: 9.51 USD
Earnings Per Share: 6.63 USD
P/E Ratio: 22.62
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 312.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 30
DGR3: 5.96%
DGR5: 5.16%
DGR10: 3.98%
DGR20: 7.45%